Feb 17, 2026 08:30AM
Jan 23, 2026 01:00AM
Dec 23, 2025 09:16AM
Dec 23, 2025 09:06AM
Dec 19, 2025 02:21PM
Nov 25, 2025 01:00AM
Oct 28, 2025 02:00AM Press release: Sanofi successfully prices USD 3 billion of bond issue
Oct 20, 2025 07:30AM
Oct 20, 2025 07:30AM
Oct 2, 2025 08:00AM
Sep 22, 2025 01:00AM
Aug 29, 2025 05:50PM
Jul 22, 2025 11:57AM
Jun 2, 2025 05:40AM Sanofi to acquire Blueprint Medicines, $129 per share
Jun 2, 2025 01:25AM
May 21, 2025 07:15PM
May 14, 2025 12:30PM
Apr 30, 2025 07:00AM
Apr 21, 2025 04:05PM
Apr 18, 2025 11:15AM
Apr 8, 2025 01:10PM Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
Mar 28, 2025 04:07PM
Mar 28, 2025 02:34PM
Mar 28, 2025 02:00AM
Mar 14, 2025 02:18PM
Feb 19, 2025 01:30AM
Dec 9, 2024 02:06PM
Nov 15, 2024 12:59AM Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
Nov 14, 2024 11:42AM
Nov 6, 2024 01:00AM
Oct 21, 2024 01:30AM
Oct 17, 2024 02:35AM
Oct 16, 2024 12:26PM
Oct 16, 2024 06:00AM
Sep 27, 2024 09:35AM Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD
Sep 27, 2024 07:01AM
Sep 27, 2024 07:00AM
Sep 20, 2024 06:36PM
Sep 13, 2024 12:16PM
Sep 13, 2024 12:15PM
Sep 12, 2024 02:37AM
Jul 10, 2024 04:10PM Sanofi ships U.S. influenza vaccines for the 2024/25 season
Jun 20, 2024 08:00AM
May 30, 2024 09:01AM
May 10, 2024 02:15AM
Apr 26, 2024 08:02AM
Apr 23, 2024 01:00AM
Feb 24, 2024 09:51AM
Jan 23, 2024 01:00AM Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
Dec 21, 2023 01:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All